Mark Jandreski

Mark Jandreski is a Principal Engineer at Recipharm, leading the Continuous RNA Process Development Group under a FDA/MIT Grant project. Prior to this, Mark was a Manager at Oncorus and a Tech Transfer Engineer III at GreenLight Biosciences. With a background in chemical engineering and health science, Mark has experience in various roles including Process Engineer at Acorda Therapeutics and Manufacturing Technician at Genzyme.